Phase None Active, not recruiting NCT04354701

The COVID-19 and Cancer Consortium (CCC19) Registry

Vanderbilt-Ingram Cancer Center · Observational

44 views
Rate this page
★ ★ ★ ★ ★
Enrollment closed (started March 2020). Expected completion: December 2029.
Lung Cancer
Study context Single-site study

Overview

In this study we will collect granular information on cancer patients infected with COVID-19, as rapidly as possible. The mechanism for collection of this information is a de-identified centralized registry housed at Vanderbilt University Medical Center, with data donations from internal and external health care professionals.

Full record on ClinicalTrials.gov (NCT ID NCT04354701).

Recruitment criteria

Age range: ≥ 18 · Sex: All · Healthy volunteers: Accepts

Study design

Phase
Phase None
Study type
Observational
Enrollment target
— participants
Started
March 2020
Estimated completion
December 2029

Outcome measures

Locations & contactsi

Filter by location Showing 1 of 1 sites

1 site currently enrolling. Representative sites shown below; full site list on ClinicalTrials.gov.

Vanderbilt University Medical Center — Nashville, Tennessee (United States)

Sources

REG
ClinicalTrials.gov — NCT04354701
Trial registry · primary record
How would you rate this page?
Your feedback helps us improve the quality of our content.
★ ★ ★ ★ ★
What did you like about this page?
What did you not like about this page?
Is there anything else you'd like to see covered?
Report an error
All reports are reviewed before any changes are made.
What type of error are you reporting?
Which section does this relate to?
Please describe the error
Be as specific as possible — include the correct information if you know it.
Highlight mode — select the text containing the error
Click and drag over the relevant text, then click Confirm.
✓
Thank you
Your response helps us improve the quality of this page.